| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.05B | — | +52.8% |
| Cost of Revenue | $3.61B | — | +52.0% |
| Gross Profit | $437.2M | — | +59.6% |
| R&D Expense | $41.2M | — | +134.1% |
| SG&A Expense | $117.4M | — | +4.4% |
| Operating Income | $272.1M | — | +111.3% |
| Pre-tax Income | $256.3M | — | +125.4% |
| Income Tax | $44.0M | — | +60.0% |
| Net Income | $212.3M | — | +146.3% |
| EPS (Basic) | $1.85 | — | +150.0% |
| EPS (Diluted) | $1.83 | — | +147.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $378.0M | -36.5% | +24.8% |
| Accounts Receivable | $3.17B | +20.1% | +48.3% |
| Inventory | $2.67B | +22.2% | +49.5% |
| Current Assets | $6.40B | +12.8% | +46.2% |
| Total Assets | $8.26B | +14.5% | +41.6% |
| Current Liabilities | $5.08B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $356.3M | — | +173.4% |
| Investing Cash Flow | -$218.4M | — | -495.1% |
| Financing Cash Flow | -$355.5M | — | -66.2% |
| +66.3% |
| Long-term Debt | $746.5M | -0.5% | -18.4% |
| Total Liabilities | $6.16B | +23.3% | +44.0% |
| Stockholders' Equity | $2.10B | -5.3% | +34.8% |